Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05910)

• Formulation Name: Digoxin 0.125 mg tablet
• Company: Avera McKennan Hospital; Cardinal Health; Concordia Pharmaceuticals; Covis Pharmaceuticals; McKesson; NCS HealthCare of KY, Inc dba Vangard Labs; NuCare Pharmaceuticals; Par Pharmaceutical; RemedyRepack; State of Florida DOH Central Pharmacy; Unit Dose Services

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Digoxin	(DMQCTIH)	Arrhythmia	BC9Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Quinoline yellow WS	(E00309)	24671	Colorant
Sunset yellow FCF	(E00255)	17730	Colorant